IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression

Journal of Immunology

Volumn 186, Issue 1, 2011, Pages 83-91

  Eller, Kathrin ^a   Wolf, Dominik ^a   Huber, Julia M ^a   Metz, Martin ^b   Mayer, Gert ^a   McKenzie, Andrew N J ^c   Maurer, Marcus ^b   Rosenkranz, Alexander R ^a   Wolf, Anna M ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 9; MONOCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; LYMPHATIC DRAINAGE; LYMPHOCYTE TRANSFER; MALE; MAST CELL; MOUSE; NEPHRITIS; NEPHROTOXIC SERUM NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; RENAL PROTECTION; WILD TYPE;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; IMMUNOSUPPRESSION; INFLAMMATION MEDIATORS; INTERLEUKIN-9; LYMPH NODES; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRITIS; T-LYMPHOCYTES, REGULATORY;

EID: 79251586227     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001183     Document Type: Article

References (52)

1. Siegmund, K., M. Feuerer, C. Siewert, S. Ghani, U. Haubold, A. Dankof, V. Krenn, M. P. Schön, A. Scheffold, J. B. Lowe, et al. 2005. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104. (Pubitemid 41565906)
2. Riley, J. L., C. H. June, and B. R. Blazar. 2009. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30: 656-665.
3. Read, S., V. Malmström, and F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
4. Mottet, C., H. H. Uhlig, and F. Powrie. 2003. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170: 3939-3943.
5. Wolf, D., K. Hochegger, A. M. Wolf, H. F. Rumpold, G. Gastl, H. Tilg, G. Mayer, E. Gunsilius, and A. R. Rosenkranz. 2005. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J. Am. Soc. Nephrol. 16: 1360-1370.
6. Seddon, B., and D. Mason. 1999. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+) CD45RC2 cells and CD4(+)CD8(2) thymocytes. J. Exp. Med. 189: 279-288.
7. Groux, H., A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J. E. de Vries, and M. G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
8. Foussat, A., F. Cottrez, V. Brun, N. Fournier, J. P. Breittmayer, and H. Groux. 2003. A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation. J. Immunol. 171: 5018-5026.
9. Serra, P., A. Amrani, J. Yamanouchi, B. Han, S. Thiessen, T. Utsugi, J. Verdaguer, and P. Santamaria. 2003. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 19: 877-889.
10. Veldhoen, M., H. Moncrieffe, R. J. Hocking, C. J. Atkins, and B. Stockinger. 2006. Modulation of dendritic cell function by naive and regulatory CD4+ T cells. J. Immunol. 176: 6202-6210.
11. Maloy, K. J., L. Salaun, R. Cahill, G. Dougan, N. J. Saunders, and F. Powrie. 2003. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197: 111-119.
12. Huang, M. T., Y. S. Dai, Y. B. Chou, Y. H. Juan, C. C. Wang, and B. L. Chiang. 2009. Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling. J. Immunol. 183: 4745-4754.
13. Gri, G., S. Piconese, B. Frossi, V. Manfroi, S. Merluzzi, C. Tripodo, A. Viola, S. Odom, J. Rivera, M. P. Colombo, and C. E. Pucillo. 2008. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29: 771-781.
14. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
15. Galli, S. J., S. Nakae, and M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6: 135-142.
16. Steinmetz, O. M., J. E. Turner, H. J. Paust, M. Lindner, A. Peters, K. Heiss, J. Velden, H. Hopfer, S. Fehr, T. Krieger, et al. 2009. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J. Immunol. 183: 4693-4704.
17. Summers, S. A., O. M. Steinmetz, M. Li, J. Y. Kausman, T. Semple, K. L. Edgtton, D. B. Borza, H. Braley, S. R. Holdsworth, and A. R. Kitching. 2009. Th1 and Th17 cells induce proliferative glomerulonephritis. J. Am. Soc. Nephrol. 20: 2518-2524.
18. Ooi, J. D., R. K. Phoon, S. R. Holdsworth, and A. R. Kitching. 2009. IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J. Am. Soc. Nephrol. 20: 980-989.
19. Paust, H. J., J. E. Turner, O. M. Steinmetz, A. Peters, F. Heymann, C. Hölscher, G. Wolf, C. Kurts, H. W. Mittrücker, R. A. Stahl, and U. Panzer. 2009. The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol. 20: 969-979.
20. Eller, K., T. Weber, M. Pruenster, A. M. Wolf, G. Mayer, A. R. Rosenkranz, and A. Rot. 2010. CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells. J. Am. Soc. Nephrol. 21: 42-52.
21. Kanamaru, Y., L. Scandiuzzi, M. Essig, C. Brochetta, C. Guérin-Marchand, Y. Tomino, R. C. Monteiro, M. Peuchmaur, and U. Blank. 2006. Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis. J. Immunol. 176: 5607-5615.
22. Hochegger, K., F. Siebenhaar, V. Vielhauer, D. Heininger, T. N. Mayadas, G. Mayer, M. Maurer, and A. R. Rosenkranz. 2005. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur. J. Immunol. 35: 3074-3082.
23. Lu, L. F., E. F. Lind, D. C. Gondek, K. A. Bennett, M. W. Gleeson, K. Pino-Lagos, Z. A. Scott, A. J. Coyle, J. L. Reed, J. Van Snick, et al. 2006. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002.
24. Colvin, R. B., and H. F. Dvorak. 1974. Letter: basophils and mast cells in renal allograft rejection. Lancet 303: 212-214.
25. Ehara, T., and H. Shigematsu. 1998. Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis. Kidney Int. 54: 1675-1683.
26. Hiromura, K., M. Kurosawa, S. Yano, and T. Naruse. 1998. Tubulointerstitial mast cell infiltration in glomerulonephritis. Am. J. Kidney Dis. 32: 593-599.
27. Tóth, T., R. Tóth-Jakatics, S. Jimi, M. Ihara, H. Urata, and S. Takebayashi. 1999. Mast cells in rapidly progressive glomerulonephritis. J. Am. Soc. Nephrol. 10: 1498-1505.
28. Townsend, J. M., G. P. Fallon, J. D. Matthews, P. Smith, E. H. Jolin, and N. A. McKenzie. 2000. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13: 573-583.
29. Rosenkranz, A. R., D. L. Mendrick, R. S. Cotran, and T. N. Mayadas. 1999. P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation. J. Clin. Invest. 103: 649-659.
30. Kitching, A. R., S. R. Holdsworth, V. A. Ploplis, E. F. Plow, D. Collen, P. Carmeliet, and P. G. Tipping. 1997. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J. Exp. Med. 185: 963-968.
31. Hochegger, K., G. L. Jansky, A. Soleiman, A. M. Wolf, A. Tagwerker, C. Seger, A. Griesmacher, G. Mayer, and A. R. Rosenkranz. 2008. Differential effects of rapamycin in anti-GBM glomerulonephritis. J. Am. Soc. Nephrol. 19: 1520-1529.
32. Rodewald, H. R., C. Waskow, and C. Haller. 2001. Essential requirement for ckit and common gamma chain in thymocyte development cannot be overruled by enforced expression of Bcl-2. J. Exp. Med. 193: 1431-1437.
33. Hauber, H. P., C. Bergeron, and Q. Hamid. 2004. IL-9 in allergic inflammation. Int. Arch. Allergy Immunol. 134: 79-87.
34. Veldhoen, M., C. Uyttenhove, J. van Snick, H. Helmby, A. Westendorf, J. Buer, B. Martin, C. Wilhelm, and B. Stockinger. 2008. Transforming growth factorbeta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9: 1341-1346.
35. Nowak, E. C., C. T. Weaver, H. Turner, S. Begum-Haque, B. Becher, B. Schreiner, A. J. Coyle, L. H. Kasper, and R. J. Noelle. 2009. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 206: 1653-1660.
36. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
37. Salama, A. D., A. N. Chaudhry, K. A. Holthaus, K. Mosley, R. Kalluri, M. H. Sayegh, R. I. Lechler, C. D. Pusey, and L. Lightstone. 2003. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int. 64: 1685-1694.
38. Salama, A. D., N. Najafian, M. R. Clarkson, W. E. Harmon, and M. H. Sayegh. 2003. Regulatory CD25+ T cells in human kidney transplant recipients. J. Am. Soc. Nephrol. 14: 1643-1651.
39. Piconese, S., G. Gri, C. Tripodo, S. Musio, A. Gorzanelli, B. Frossi, R. Pedotti, C. E. Pucillo, and M. P. Colombo. 2009. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 114: 2639-2648.
40. Forward, N. A., S. J. Furlong, Y. Yang, T. J. Lin, and D. W. Hoskin. 2009. Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction. J. Immunol. 183: 3014-3022.
41. Kambayashi, T., E. J. Allenspach, J. T. Chang, T. Zou, J. E. Shoag, S. L. Reiner, A. J. Caton, and G. A. Koretzky. 2009. Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J. Immunol. 182: 4686-4695.
42. Lee, D. M., D. S. Friend, M. F. Gurish, C. Benoist, D. Mathis, and M. B. Brenner. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297: 1689-1692.
43. Gregory, G. D., M. Robbie-Ryan, V. H. Secor, J. J. Sabatino, Jr., and M. A. Brown. 2005. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 35: 3478-3486.
44. Grimbaldeston, M. A., C. C. Chen, A. M. Piliponsky, M. Tsai, S. Y. Tam, and S. J. Galli. 2005. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167: 835-848.
45. Elyaman, W., E. M. Bradshaw, C. Uyttenhove, V. Dardalhon, A. Awasthi, J. Imitola, E. Bettelli, M. Oukka, J. van Snick, J. C. Renauld, et al. 2009. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 12885-12890.
46. Hallgren, J., and M. F. Gurish. 2007. Pathways ofmurine mast cell development and trafficking: tracking the roots and routes of the mast cell. Immunol. Rev. 217: 8-18.
47. Abonia, J. P., K. F. Austen, B. J. Rollins, S. K. Joshi, R. A. Flavell, W. A. Kuziel, P. A. Koni, and M. F. Gurish. 2005. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 105: 4308-4313.
48. Mazzoni, A., H. A. Young, J. H. Spitzer, A. Visintin, and D. M. Segal. 2001. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 108: 1865-1873.
49. Caron, G., Y. Delneste, E. Roelandts, C. Duez, N. Herbault, G. Magistrelli, J. Y. Bonnefoy, J. Pestel, and P. Jeannin. 2001. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J. Immunol. 166: 6000-6006. (Pubitemid 32440724)
50. Tanda, S., Y. Mori, T. Kimura, K. Sonomura, T. Kusaba, N. Kishimoto, H. Kameyama, K. Tamagaki, M. Okigaki, T. Hatta, et al. 2007. Histamine ameliorates anti-glomerular basement membrane antibody-induced glomerulonephritis in rats. Kidney Int. 72: 608-613.
51. Grimbaldeston, M. A., S. Nakae, J. Kalesnikoff, M. Tsai, and S. J. Galli. 2007. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 8: 1095-1104.
52. de Vries, V. C., K. Pino-Lagos, R. Elgueta, and R. J. Noelle. 2009. The enigmatic role of mast cells in dominant tolerance. Curr. Opin. Organ Transplant. 14: 332-337.